glp-1 receptor brain Septal Glucagon-Like Peptide 1 Expression Determines Suppression of Cocaine-Induced Behavior GLP-1 and the Degenerating Brain:

It was reported that the weight loss property of most GLP-1 analogs, except for semaglutide administered subcutaneously once weekly of smoother pharmacokinetics, is hampered by the therapeutic window because of the dose-dependent side-effects 10,11

Other concerning symptoms that necessitate medical consultation include: Severe abdominal distension or inability to pass gas/stool (possible ileus or bowel obstruction) Nausea that worsens rather than improves after 812 weeks Inability to maintain adequate nutrition or hydration Unintentional weight loss exceeding clinical targets New or worsening heartburn or reflux symptoms Visual changes (especially with rapid blood sugar improvement) Severe headache or altered mental status Signs of gallbladder disease (right upper quadrant pain, especially after eating) Hypoglycemia symptoms if taking insulin or sulfonylureas Patients should generally not discontinue GLP-1 medications without medical guidance, except in emergencies such as suspected pancreatitis or severe allergic reaction

Its pathogenesis involves a dysfunctional immune response whereby the immune system erroneously attacks synovial tissue[17]

2021;29(7):679693 e676

For this reason, the upper arm is most practical when someone else administers the injection for you, or when you are using a pre-filled pen device that simplifies the process

They are often frustrated, exhausted, and unsure where to turn next